Macrophage Inflammatory Protein-1alpha Mediates Matrix Metalloproteinase-9 Enhancement in Human Adherent Monocytes Fed with Malarial Pigment
Overview
Tropical Medicine
Affiliations
Objective: To investigate the role of macrophage inflammatory protein-1alpha (MIP-1alpha) in the detrimental enhancement of matrix metalloproteinase-9 (MMP-9) expression, release and activity induced by phagocytosis of malarial pigment (haemozoin, HZ) in human monocytes.
Methods: Human adherent monocytes were unfed/fed with native HZ for 2 h. After 24 hours, MIP-1alpha production was evaluated by ELISA in cell supernatants. Alternatively, HZ-unfed/fed monocytes were treated in presence/absence of anti-human MIP-1alpha blocking antibodies or recombinant human MIP-1alpha for 15 h (RNA studies) or 24 h (protein studies); therefore, MMP-9 mRNA expression was evaluated in cell lysates by Real Time RT-PCR, whereas proMMP-9 and active MMP-9 protein release were measured in cell supernatants by Western blotting and gelatin zymography.
Results: Phagocytosis of HZ by human monocytes increased production of MIP-1 alpha, mRNA expression of MMP-9 and protein release of proMMP-9 and active MMP-9. All the HZ-enhancing effects on MMP-9 were abrogated by anti-human MIP-1alpha blocking antibodies and mimicked by recombinant human MIP-1alpha.
Conclusions: The present work suggests a role for MIP-1alpha in the HZ-dependent enhancement of MMP-9 expression, release and activity observed in human monocytes, highlighting new detrimental effects of HZ-triggered proinflammatory response by phagocytic cells in falciparum malaria.
Turini S, Bergandi L, Gazzano E, Prato M, Aldieri E Int J Mol Sci. 2019; 20(1).
PMID: 30609805 PMC: 6337211. DOI: 10.3390/ijms20010150.
Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm.
Di Gennaro A, Araujo A, Busch A, Jin H, Wagsater D, Vorkapic E Proc Natl Acad Sci U S A. 2018; 115(8):1907-1912.
PMID: 29432192 PMC: 5828611. DOI: 10.1073/pnas.1717906115.
Costa A, Ramasawmy R, Santos Ibiapina H, Sampaio V, Xabregas L, Brasil L PLoS One. 2017; 12(8):e0183840.
PMID: 28850598 PMC: 5574562. DOI: 10.1371/journal.pone.0183840.
Gulino G, Polimeni M, Prato M, Gazzano E, Kopecka J, Colombatto S Environ Health Perspect. 2015; 124(6):776-84.
PMID: 26685284 PMC: 4892914. DOI: 10.1289/ehp.1409627.
Polimeni M, Prato M Fluids Barriers CNS. 2014; 11(1):1.
PMID: 24467887 PMC: 3905658. DOI: 10.1186/2045-8118-11-1.